1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ankylosing Spondylitis Treatment Drug Market Size 2016-2026
2.1.2 Ankylosing Spondylitis Treatment Drug Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Ankylosing Spondylitis Treatment Drug Segment by Type
2.2.1 Non-steroidal Anti-inflammatory Drugs
2.2.2 Non-steroidal Anti-inflammatory Drugs
2.3 Ankylosing Spondylitis Treatment Drug Market Size by Type
2.3.1 Global Ankylosing Spondylitis Treatment Drug Market Size CAGR by Type
2.3.2 Global Ankylosing Spondylitis Treatment Drug Market Size Market Share by Type (2016-2021)
2.4 Ankylosing Spondylitis Treatment Drug Segment by Sales Channel
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Online Pharmacy
2.4.4 Other
2.5 Ankylosing Spondylitis Treatment Drug Market Size by Sales Channel
2.5.1 Global Ankylosing Spondylitis Treatment Drug Market Size CAGR by Sales Channel
2.5.2 Global Ankylosing Spondylitis Treatment Drug Market Size Market Share by Sales Channel (2016-2021)

3 Ankylosing Spondylitis Treatment Drug Market Size by Players
3.1 Ankylosing Spondylitis Treatment Drug Market Size Market Share by Players
3.1.1 Global Ankylosing Spondylitis Treatment Drug Revenue by Players (2019-2021E)
3.1.2 Global Ankylosing Spondylitis Treatment Drug Revenue Market Share by Players (2019-2021E)
3.2 Global Ankylosing Spondylitis Treatment Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Ankylosing Spondylitis Treatment Drug by Regions
4.1 Ankylosing Spondylitis Treatment Drug Market Size by Regions (2016-2021)
4.2 Americas Ankylosing Spondylitis Treatment Drug Market Size Growth (2016-2021)
4.3 APAC Ankylosing Spondylitis Treatment Drug Market Size Growth (2016-2021)
4.4 Europe Ankylosing Spondylitis Treatment Drug Market Size Growth (2016-2021)
4.5 Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size Growth (2016-2021)

5 Americas
5.1 Americas Ankylosing Spondylitis Treatment Drug Market Size by Country (2016-2021)
5.2 Americas Ankylosing Spondylitis Treatment Drug Market Size by Type (2016-2021)
5.3 Americas Ankylosing Spondylitis Treatment Drug Market Size by Sales Channel (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Ankylosing Spondylitis Treatment Drug Market Size by Region (2016-2021)
6.2 APAC Ankylosing Spondylitis Treatment Drug Market Size by Type (2016-2021)
6.3 APAC Ankylosing Spondylitis Treatment Drug Market Size by Sales Channel (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Ankylosing Spondylitis Treatment Drug by Country (2016-2021)
7.2 Europe Ankylosing Spondylitis Treatment Drug Market Size by Type (2016-2021)
7.3 Europe Ankylosing Spondylitis Treatment Drug Market Size by Sales Channel (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Ankylosing Spondylitis Treatment Drug by Region (2016-2021)
8.2 Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size by Type (2016-2021)
8.3 Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size by Sales Channel (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Ankylosing Spondylitis Treatment Drug Market Forecast
10.1 Global Ankylosing Spondylitis Treatment Drug Forecast by Regions (2021-2026)
10.1.1 Global Ankylosing Spondylitis Treatment Drug Forecast by Regions (2021-2026)
10.1.2 Americas Ankylosing Spondylitis Treatment Drug Forecast
10.1.3 APAC Ankylosing Spondylitis Treatment Drug Forecast
10.1.4 Europe Ankylosing Spondylitis Treatment Drug Forecast
10.1.5 Middle East & Africa Ankylosing Spondylitis Treatment Drug Forecast
10.2 Americas Ankylosing Spondylitis Treatment Drug Forecast by Countries (2021-2026)
10.2.1 United States Ankylosing Spondylitis Treatment Drug Market Forecast
10.2.2 Canada Ankylosing Spondylitis Treatment Drug Market Forecast
10.2.3 Mexico Ankylosing Spondylitis Treatment Drug Market Forecast
10.2.4 Brazil Ankylosing Spondylitis Treatment Drug Market Forecast
10.3 APAC Ankylosing Spondylitis Treatment Drug Forecast by Region (2021-2026)
10.3.1 China Ankylosing Spondylitis Treatment Drug Market Forecast
10.3.2 Japan Ankylosing Spondylitis Treatment Drug Market Forecast
10.3.3 Korea Ankylosing Spondylitis Treatment Drug Market Forecast
10.3.4 Southeast Asia Ankylosing Spondylitis Treatment Drug Market Forecast
10.3.5 India Ankylosing Spondylitis Treatment Drug Market Forecast
10.3.6 Australia Ankylosing Spondylitis Treatment Drug Market Forecast
10.4 Europe Ankylosing Spondylitis Treatment Drug Forecast by Country (2021-2026)
10.4.1 Germany Ankylosing Spondylitis Treatment Drug Market Forecast
10.4.2 France Ankylosing Spondylitis Treatment Drug Market Forecast
10.4.3 UK Ankylosing Spondylitis Treatment Drug Market Forecast
10.4.4 Italy Ankylosing Spondylitis Treatment Drug Market Forecast
10.4.5 Russia Ankylosing Spondylitis Treatment Drug Market Forecast
10.5 Middle East & Africa Ankylosing Spondylitis Treatment Drug Forecast by Region (2021-2026)
10.5.1 Egypt Ankylosing Spondylitis Treatment Drug Market Forecast
10.5.2 South Africa Ankylosing Spondylitis Treatment Drug Market Forecast
10.5.3 Israel Ankylosing Spondylitis Treatment Drug Market Forecast
10.5.4 Turkey Ankylosing Spondylitis Treatment Drug Market Forecast
10.5.5 GCC Countries Ankylosing Spondylitis Treatment Drug Market Forecast
10.6 Global Ankylosing Spondylitis Treatment Drug Forecast by Type (2021-2026)
10.7 Global Ankylosing Spondylitis Treatment Drug Forecast by Sales Channel (2021-2026)

11 Key Players Analysis
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Ankylosing Spondylitis Treatment Drug Product Offered
11.1.3 Abbott Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Ankylosing Spondylitis Treatment Drug Product Offered
11.2.3 Merck Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 Eisai
11.3.1 Eisai Company Information
11.3.2 Eisai Ankylosing Spondylitis Treatment Drug Product Offered
11.3.3 Eisai Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Eisai Main Business Overview
11.3.5 Eisai Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Ankylosing Spondylitis Treatment Drug Product Offered
11.4.3 Novartis Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Ankylosing Spondylitis Treatment Drug Product Offered
11.5.3 Pfizer Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Johson & Johson
11.6.1 Johson & Johson Company Information
11.6.2 Johson & Johson Ankylosing Spondylitis Treatment Drug Product Offered
11.6.3 Johson & Johson Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Johson & Johson Main Business Overview
11.6.5 Johson & Johson Latest Developments
11.7 Abbive
11.7.1 Abbive Company Information
11.7.2 Abbive Ankylosing Spondylitis Treatment Drug Product Offered
11.7.3 Abbive Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Abbive Main Business Overview
11.7.5 Abbive Latest Developments
11.8 UCB
11.8.1 UCB Company Information
11.8.2 UCB Ankylosing Spondylitis Treatment Drug Product Offered
11.8.3 UCB Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 UCB Main Business Overview
11.8.5 UCB Latest Developments
11.9 Amgen
11.9.1 Amgen Company Information
11.9.2 Amgen Ankylosing Spondylitis Treatment Drug Product Offered
11.9.3 Amgen Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Amgen Main Business Overview
11.9.5 Amgen Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Ankylosing Spondylitis Treatment Drug Product Offered
11.10.3 Takeda Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
11. Mitsubishi Tanabe
11.11.1 Mitsubishi Tanabe Company Information
11.11.2 Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Product Offered
11.11.3 Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Mitsubishi Tanabe Main Business Overview
11.11.5 Mitsubishi Tanabe Latest Developments
11.12 Hisun Pharm
11.12.1 Hisun Pharm Company Information
11.12.2 Hisun Pharm Ankylosing Spondylitis Treatment Drug Product Offered
11.12.3 Hisun Pharm Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Hisun Pharm Main Business Overview
11.12.5 Hisun Pharm Latest Developments
11.13 Guojian Pharmaceutical
11.13.1 Guojian Pharmaceutical Company Information
11.13.2 Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Product Offered
11.13.3 Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Guojian Pharmaceutical Main Business Overview
11.13.5 Guojian Pharmaceutical Latest Developments
11.14 Bio-Thera Solutions
11.14.1 Bio-Thera Solutions Company Information
11.14.2 Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Product Offered
11.14.3 Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Bio-Thera Solutions Main Business Overview
11.14.5 Bio-Thera Solutions Latest Developments
11.15 Maibo Pharma
11.15.1 Maibo Pharma Company Information
11.15.2 Maibo Pharma Ankylosing Spondylitis Treatment Drug Product Offered
11.15.3 Maibo Pharma Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Maibo Pharma Main Business Overview
11.15.5 Maibo Pharma Latest Developments
11.16 Celgen Pharm
11.16.1 Celgen Pharm Company Information
11.16.2 Celgen Pharm Ankylosing Spondylitis Treatment Drug Product Offered
11.16.3 Celgen Pharm Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 Celgen Pharm Main Business Overview
11.16.5 Celgen Pharm Latest Developments

12 Research Findings and Conclusion